Oct.15 -- Roche Holding AG Chief Executive Officer Severin Schwan discusses the antibody cocktail that the Swiss drugmaker is developing with Regeneron Pharmaceuticals Inc. to treat Covid-19. He speaks from Basel, Switzerland, on "Bloomberg Markets: European Open" after Roche's third-quarter sales fell short of estimates.
•Oct 15, 2020 @ time of upload to this blog
No comments:
Post a Comment